Global Drug Discovery Technologies Market to 2030 | Major Players Include Merck, Agilent, Astrazeneca and Shimadzu
DUBLIN, Oct. 4, 2021 /PRNewswire/ -- The "Drug Discovery Technologies Market - Market Size & Forecasting to 2030" report has been added to ResearchAndMarkets.com's offering.
The global drug discovery technologies market in the COVID-19 period has been estimated to value USD 37,500.3 million in 2021 and is projected to reach USD 63,285.3 million by 2030 with a CAGR of 6.0%. However, without the COVID-19 impact, the global drug discovery technologies market was estimated to be USD 37,514.9 million in 2021 and reach USD 62,505.1 million by 2030 with a CAGR of 5.8%.
Drug discovery technologies find applications in drug discovery to diagnose cardiovascular, oncology-related, neurological, and other diseases. Increasing prevalence of chronic diseases has led to the drug discovery technologies market growth. Companies operating in the drug discovery technologies market are focusing on improving treatments and therapies by offering superior technologies.
The pharmaceutical industry is adopting multiple approaches to drug discovery. Current drug discovery technologies use modern techniques like high throughput screening, bioinformatics, structural-based drug design, and others in drug development and discovery. Advancements in biochemical, translational, and molecular studies in biomedical research have led to the commercial development of new and effective drug discovery technologies. Collaborations and partnerships among researchers and the biopharmaceutical industry have led to the innovation of advanced technologies. Furthermore, growing drug discovery start-ups having various drug candidates in clinical trial stage is expected to boost the market growth. Also, adoption of artificial intelligence (AI) in drug discovery by existing companies is further fuelling the market growth.
The spread of coronavirus has resulted in tremendous pressure on the healthcare sector. The COVID-19 outbreak has thrown a spotlight on the need to develop medicines and increase disease detection and prevention efficiency around the world. Hence, the demand for drug discovery technologies has surged significantly, and the market is experiencing rapid growth.
Major players operating in this market include Thermofisher Scietific, Merck KGAA, Agilent, Astrazeneca, F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories Inc., Perkinelmer, Incyte, Gyros Protein Technologies, Evotec, Chembridge, Charles River Laboratories, Tecan Trading AG, Shimadzu Corporation and Eurofins Discovery. However, the market is dominated by companies such as F. Hoffmann-La Roche Ltd, Thermofisher Scietific, Merck KGAA, Agilent and Astrazeneca among others. The dominance is due to their vast product portfolio in drug discovery technologies industry such as spectrometry instruments, micro plate readers, microarrays and the recent introduction of AI based softwares in drug discovery. Additionally, companies have adopted merger & acquition and collaboration as their main strategy. Such strategies have helped these companies in developing and launching numerous drugs and pharmaceutical products for tackling the increasing burden of diseases regionally. Also, the recent outbreak of COVID 19 pandemic have resulted in developing cost-effective vaccines in short period of times, there by creating many lucrative opportunities for major players operating in the market.
What does this report Provide
- Global market and submarket forecasts, with supporting analysis, for the years 2021 to 2030.
- Analysis of game-changing technological trends and how they will shape the industry
- SWOT analysis of the sector conclusions and suggestions for the market
- Detailed Segmentation to help each stakeholder in market
- 2500+ data points in 60+ tables with focus on historic demand, estimated demand, and demand forecast
- Impact of COVID-19 on demand estimation & forecasts (2020 onward)
- Separate analysis of each segment to understand market deviation due to Covid-19 from 2020 onwards
- Coverage across 5 major regions: North America, Europe, Asia Pacific, Middle East & Africa, and South America
- Country level demand of the 25+ major markets with key trends & factors influencing the same
The drug discovery technologies market report can assist government agencies, state insurance systems, private insurance companies, pharmacists and health-care staff, pharmaceutical industry, wholesalers, regulatory authorities etc.
Key Topics Covered:
1. Market Abstract
2. Market Introduction
3. Research Practice
4. Key Related Data
5. Impact Factor Analysis
6. Market Development Analysis
7. Drug Discovery Technologies Market, by Technology
8. Drug Discovery Technologies Market, by Application
9. Drug Discovery Technologies Market, by End-user
10. Drug Discovery Technologies Market, Regional Analysis
11. Global Drug Discovery Technologies Market, Competitve Intelligence
12. Company Profiles
13. Appendix
Companies Mentioned
- Bio-Rad Laboratories Inc.
- Perkinelmer Inc. Incyte
- Gyros Protein Technologies
- Evotec
- Thermo Fisher Scientific Inc.
- Agilent Technologies Inc.
- Astrazeneca
- F. Hoffmann- La Roche Ltd.
- Merck Kgaa
- Charles Laboratories International Inc.
- Tecan
- Shimadzu Corporation
- Eurofins Scientific
- Chembridge Corporation
For more information about this report visit https://www.researchandmarkets.com/r/kvx081
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Share this article